Statin therapy with ezetimibe or niacin in high-risk patients.
Kastelein
John J P
JJ
Bots
Michiel L
ML
D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use; D002339:Carotid Arteries / Q000187:drug effects* / Q000473:pathology; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy / Q000473:pathology; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009525:Niacin / Q000494:pharmacology / Q000627:therapeutic use*; D012107:Research Design; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology
D000924:Anticholesteremic Agents; D001384:Azetidines; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003692:Delayed-Action Preparations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009525:Niacin; D000069438:Ezetimibe